# A Study of LY3502970 in Healthy Participants

> **NCT03929744** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 133 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3502970
- **DRUG:** Placebo
- **DRUG:** Atorvastatin
- **DRUG:** Simvastatin
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT03929744
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-12
- **Primary completion:** 2020-11-02
- **Final completion:** 2020-11-02
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2020-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03929744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03929744, "A Study of LY3502970 in Healthy Participants". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03929744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*